Medical Imaging Reagents Market (By Modality: X-ray, CT Scan, Ultrasound, MRI Scan; By Class: Contrast Reagent, Optical Reagent, Nuclear Reagent; By Application: Neurological Disorder, Cardiovascular Disorder, Cancer, Gastrointestinal Disorder, Musculoskeletal Disorder, Nephrological Disorder, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Imaging Reagents Market
5.1. COVID-19 Landscape: Medical Imaging Reagents Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Imaging Reagents Market, By Modality
8.1. Medical Imaging Reagents Market, by Modality, 2023-2032
8.1.1 X-ray
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. CT Scan
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Ultrasound
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. MRI Scan
8.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Medical Imaging Reagents Market, By Class
9.1. Medical Imaging Reagents Market, by Class, 2023-2032
9.1.1. Contrast Reagent
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Optical Reagent
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Nuclear Reagent
9.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Medical Imaging Reagents Market, By Application
10.1. Medical Imaging Reagents Market, by Application, 2023-2032
10.1.1. Neurological Disorder
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Cardiovascular Disorder
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Cancer
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Gastrointestinal Disorder
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. Musculoskeletal Disorder
10.1.5.1. Market Revenue and Forecast (2021-2032)
10.1.6. Nephrological Disorder
10.1.6.1. Market Revenue and Forecast (2021-2032)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Medical Imaging Reagents Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Modality (2021-2032)
11.1.2. Market Revenue and Forecast, by Class (2021-2032)
11.1.3. Market Revenue and Forecast, by Application (2021-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Modality (2021-2032)
11.1.4.2. Market Revenue and Forecast, by Class (2021-2032)
11.1.4.3. Market Revenue and Forecast, by Application (2021-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Modality (2021-2032)
11.1.5.2. Market Revenue and Forecast, by Class (2021-2032)
11.1.5.3. Market Revenue and Forecast, by Application (2021-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Modality (2021-2032)
11.2.2. Market Revenue and Forecast, by Class (2021-2032)
11.2.3. Market Revenue and Forecast, by Application (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Modality (2021-2032)
11.2.4.2. Market Revenue and Forecast, by Class (2021-2032)
11.2.4.3. Market Revenue and Forecast, by Application (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Modality (2021-2032)
11.2.5.2. Market Revenue and Forecast, by Class (2021-2032)
11.2.5.3. Market Revenue and Forecast, by Application (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Modality (2021-2032)
11.2.6.2. Market Revenue and Forecast, by Class (2021-2032)
11.2.6.3. Market Revenue and Forecast, by Application (2021-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Modality (2021-2032)
11.2.7.2. Market Revenue and Forecast, by Class (2021-2032)
11.2.7.3. Market Revenue and Forecast, by Application (2021-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Modality (2021-2032)
11.3.2. Market Revenue and Forecast, by Class (2021-2032)
11.3.3. Market Revenue and Forecast, by Application (2021-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Modality (2021-2032)
11.3.4.2. Market Revenue and Forecast, by Class (2021-2032)
11.3.4.3. Market Revenue and Forecast, by Application (2021-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Modality (2021-2032)
11.3.5.2. Market Revenue and Forecast, by Class (2021-2032)
11.3.5.3. Market Revenue and Forecast, by Application (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Modality (2021-2032)
11.3.6.2. Market Revenue and Forecast, by Class (2021-2032)
11.3.6.3. Market Revenue and Forecast, by Application (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Modality (2021-2032)
11.3.7.2. Market Revenue and Forecast, by Class (2021-2032)
11.3.7.3. Market Revenue and Forecast, by Application (2021-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Modality (2021-2032)
11.4.2. Market Revenue and Forecast, by Class (2021-2032)
11.4.3. Market Revenue and Forecast, by Application (2021-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Modality (2021-2032)
11.4.4.2. Market Revenue and Forecast, by Class (2021-2032)
11.4.4.3. Market Revenue and Forecast, by Application (2021-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Modality (2021-2032)
11.4.5.2. Market Revenue and Forecast, by Class (2021-2032)
11.4.5.3. Market Revenue and Forecast, by Application (2021-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Modality (2021-2032)
11.4.6.2. Market Revenue and Forecast, by Class (2021-2032)
11.4.6.3. Market Revenue and Forecast, by Application (2021-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Modality (2021-2032)
11.4.7.2. Market Revenue and Forecast, by Class (2021-2032)
11.4.7.3. Market Revenue and Forecast, by Application (2021-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Modality (2021-2032)
11.5.2. Market Revenue and Forecast, by Class (2021-2032)
11.5.3. Market Revenue and Forecast, by Application (2021-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Modality (2021-2032)
11.5.4.2. Market Revenue and Forecast, by Class (2021-2032)
11.5.4.3. Market Revenue and Forecast, by Application (2021-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Modality (2021-2032)
11.5.5.2. Market Revenue and Forecast, by Class (2021-2032)
11.5.5.3. Market Revenue and Forecast, by Application (2021-2032)
Chapter 12. Company Profiles
12.1. Abbott Bracco Spa
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Lantheus Holdings, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. General Electric Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Siemens AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bayer AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CMC Contrast AB
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Thermo Fisher Scientific Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Merck & Co., Inc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Shimadzu Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Koninklijke Philips N.V.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client